Cart
sales@molnova.com
(2RS)-FPMPA
CAS No. 135295-27-1
(2RS)-FPMPA( —— )
Catalog No. M35992 CAS No. 135295-27-1
(2RS)-FPMPA（FPMPA） has antiviral activity with an IC50 value of 1.85 μM measured in human MT12 cells infected with SHIV (DH4R).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 610 | In Stock |
|
| 10MG | 867 | In Stock |
|
| 25MG | 1302 | In Stock |
|
| 50MG | 1721 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(2RS)-FPMPA
-
NoteResearch use only, not for human use.
-
Brief Description(2RS)-FPMPA（FPMPA） has antiviral activity with an IC50 value of 1.85 μM measured in human MT12 cells infected with SHIV (DH4R).
-
Description(2RS)-FPMPA can be used for synthesis of antiretroviral agents against HIV-1 and HIV-2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number135295-27-1
-
Formula Weight305.2
-
Molecular FormulaC9H13FN5O4P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(OCP(=O)(O)O)CF)N1C=2C(N=C1)=C(N)N=CN2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Balzarini J, et al. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4961-5. ?
molnova catalog
related products
-
IMB-301
IMB-301 (NSC 301209) is a small molecule inhibitor that target the binding interface of the HIV-1 Vif/hA3G complex.
-
MUT-A
MUT-A is a novel potent, HIV-1 Integrase IN-LEDGF allosteric inhibitor, shows potent anti-HIV activity with EC50 of 32 nM and 12 nM for NL4-3 or HxB2 HIV-1 strains, respectively.
-
Tenofovir alafenamid...
Tenofovir alafenamide fumarate (TAF) is an oral phosphonoamidate prodrug of the HIV reverse transcriptase nucleotide inhibitor tenofovir (TFV).
